Different response rates to low-dose cytosine arabinoside in acute myeloid leukemia subtypes.
Lutz
D
D
Krieger
O
O
Ihle
R
R
Fekete
S
S
Minigo
H
H
Nowotny
H
H
Kasparu
H
H
Tüchler
H
H
Köller
U
U
D000367:Age Factors; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000188:drug therapy* / Q000235:genetics; D011379:Prognosis
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D003561:Cytarabine